Key facts
- This page summarizes Michael Carulli's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Mar 2026, 16:41.
Michael Carulli - 05 Mar 2026 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- PMVP
- Reported as of
- 05 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2026, 16:41:27 UTC
- Prior SEC filing
- 03 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Ticktin, by power ot attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Carulli filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 09 Mar 2026.
Change
- Previous filing in this sequence was filed on 03 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002006668
Primary reporting owner
Carulli Michael
- Relationship
- Chief Financial Officer
- Address
- C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON
- Signature
- /s/ Robert Ticktin, by power ot attorney
- Signature date
- 09 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMVP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 73,848
- Date
- 05 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PMVP
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- Shares
- +240,000
- Change %
- Price
- $0.000000*
- Shares after
- 240,000
- Date
- 05 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 240,000
- Exercise price
- $1.53
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 13,702 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025.
Footnote F2
Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026.